Curevac N.V. (NQ: CVAC )

96.18 +1.88 (+1.99%)

Official Closing Price Updated: 7:42 PM EST, Mar 1, 2021 Add to My Watchlist

Price and Volume

Volume	741,800
Open	95.48
Bid (Size)	96.00 (2)
Ask (Size)	96.80 (1)
Prev. Close	94.30
Today's Range	94.98 - 97.00
52wk Range	36.15 - 151.80
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

CureVac to Participate in Upcoming Investor Conferences

February 18, 2021

CureVac Initiates Rolling Submission With European Medicines Agency for COVID-19 Vaccine Candidate, CVnCoV

February 12, 2021

Performance

YTD	+13.02%	+13.02%
1 Month	+1.72%	+1.72%
3 Month	-8.55%	-8.55%
6 Month	+74.62%	+74.62%
1 Year	+72.06%	+72.06%

More News

CureVac to Host Conference Call on COVID-19 Partnership Update on February 5, 2021

February 05, 2021

CureVac and UK Government to Collaborate on Development of Vaccines Against SARS-CoV-2 Variants

February 05, 2021

Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg

February 26, 2021

CureVac Expands Lead RNA Cancer Program Phase 1 Trial in Advanced Melanoma

February 04, 2021

Moderna Raises 2021 Base COVID-19 Vaccine Production Plan To 700M Doses

February 25, 2021

CureVac Announces Full Exercise of Underwriters' Option to Purchase Additional Common Shares

February 04, 2021

Moderna To Test New COVID-19 Vaccine Targeting South Africa Strain

February 25, 2021

FDA Says Conduct Smaller Trials To Test Vaccine Efficacy Against COVID Variants

February 23, 2021

Sanofi/GlaxoSmithKline Initiate COVID-19 Vaccine Development After Setback

February 22, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.